Transplacentally acquired organophosphorus poisoning in a newborn: case report.
A term neonate was born to a mother who had consumed an organophosphorus compound with suicidal intent 50 hours before delivery. At birth, the infant showed signs and symptoms of organophosphorus poisoning and was treated with atropine and pralidoxime to which she responded well. Unfortunately, the mother died despite appropriate treatment. This is only the second report documenting transplacental organophosphate poisoning.
Jajoo
M
M
Department of Pediatrics, Maulana Azad Medical College and associated Chacha Nehru Bal Chikitsalaya, India. jajoomamta@yahoo.co.in
Saxena
S
S
Pandey
M
M
D000992:Antitoxins / Q000627:therapeutic use; D001285:Atropine / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D010755:Organophosphates / Q000633:toxicity*; D011041:Poisoning / Q000175:diagnosis* / Q000188:drug therapy / Q000473:pathology*; D011220:Pralidoxime Compounds / Q000627:therapeutic use; D011247:Pregnancy; D011248:Pregnancy Complications; D013406:Suicide, Attempted
D000992:Antitoxins; D010755:Organophosphates; D011220:Pralidoxime Compounds; D001285:Atropine; C028797:pralidoxime